相关实验视频
Updated: Jun 19, 2025

20:28
A Toolkit to Enable Hydrocarbon Conversion in Aqueous Environments
Published on: October 2, 2012
14.1K
来自Sphingobacterium siyangense SY1的新基因降解酶的基于结构的重塑,以α-haloacetophenones为准
Changli Che1, Wenhe Zhang1, Xin Xu1
1School of Life Sciences and Biopharmaceutical Sciences, Shenyang Pharmaceutical University, 103 Wenhua Road, Shenhe, Shenyang 110016, People's Republic of China.
International journal of biological macromolecules
|July 26, 2024
概括
研究人员设计了一种减酶,SssDR1,用于高效的性合成. 一种突变酶对化乙,关键药物中间体,提高了生物催化效率.
科学领域:
- 生物催化剂是一种生物催化剂.
- 酶工程是什么? 酶工程是什么?
- 有机合成 有机合成
背景情况:
- 降酶对于合成性药物中间体至关重要.
- 了解酶基质选择性可以提高酶工程的效率.
研究的目的:
- 为了识别和表征一种来自Sphingobacterium siyangense SY1.1.的新型降酶,SssDR1.
- 为了研究SssDR1对化乙芬的基质选择性.
- 为了改造SssSDR1以提高对α-化乙烯的活性.
主要方法:
- 基因挖掘和SssDR1在大肠杆菌中的功能表达.
- 酶活性测定使用各种亚塞托芬基质.
- 进行X射线晶体学以确定酶结构.
- 基于结构洞察力的理性酶工程.
主要成果:
- SsSDR1对3,5-bis(trifluoromethyl) acetophenone (1f) 的活性很高,这是阿普雷皮坦的前体.
- SsSDR1显示,它更喜欢非α-化乙烯基子,而不是α-化乙烯基.
- 一种突变的酶,I144A/S153L,显示出对α-化乙烯的显著改善活性.
- 在1f和2-chloro-1-(3,4-difluorophenyl) 乙 (1i) 的不对称催化过程中获得了高的时空产量 (STY).
结论:
- SsSDR1是一种有价值的生物催化剂,用于合成化乙烯.
- 酶工程可以增强缩酶的活性和选择性.
- 结构洞察力指导了针对特定基质的酶的合理设计.
相关概念视频
Alcohols from Carbonyl Compounds: Reduction
10.2K
Reduction is a simple strategy to convert a carbonyl group to a hydroxyl group. The three major pathways to reduce carbonyls to alcohols are catalytic hydrogenation, hydride reduction, and borane reduction.
Catalytic hydrogenation is similar to the reduction of an alkene or alkyne by adding H2 across the pi bond in the presence of transition metal catalysts like Raney Ni, Pd–C, Pt, or Ru. Aldehydes and ketones can be reduced by this method, often under mild to moderate heat (25–100°C) and...
Catalytic hydrogenation is similar to the reduction of an alkene or alkyne by adding H2 across the pi bond in the presence of transition metal catalysts like Raney Ni, Pd–C, Pt, or Ru. Aldehydes and ketones can be reduced by this method, often under mild to moderate heat (25–100°C) and...
10.2K
Reduction of Alkenes: Asymmetric Catalytic Hydrogenation
3.3K
Catalytic hydrogenation of alkenes is a transition-metal catalyzed reduction of the double bond using molecular hydrogen to give alkanes. The mode of hydrogen addition follows syn stereochemistry.
The metal catalyst used can be either heterogeneous or homogeneous. When hydrogenation of an alkene generates a chiral center, a pair of enantiomeric products is expected to form. However, an enantiomeric excess of one of the products can be facilitated using an enantioselective reaction or an...
The metal catalyst used can be either heterogeneous or homogeneous. When hydrogenation of an alkene generates a chiral center, a pair of enantiomeric products is expected to form. However, an enantiomeric excess of one of the products can be facilitated using an enantioselective reaction or an...
3.3K
Acid-Catalyzed α-Halogenation of Aldehydes and Ketones
3.7K
By replacing an α-hydrogen with a halogen, acid-catalyzed α-halogenation of aldehydes or ketones yields a monohalogenated product
In the first step of the mechanism, the acid protonates the carbonyl oxygen resulting in a resonance-stabilized cation, which subsequently loses an α-hydrogen to form an enol tautomer. The C=C bond in an enol is highly nucleophilic because of the electron-donating nature of the –OH group. Consequently, the double bond attacks an electrophilic halogen to form a...
In the first step of the mechanism, the acid protonates the carbonyl oxygen resulting in a resonance-stabilized cation, which subsequently loses an α-hydrogen to form an enol tautomer. The C=C bond in an enol is highly nucleophilic because of the electron-donating nature of the –OH group. Consequently, the double bond attacks an electrophilic halogen to form a...
3.7K
Aldehydes and Ketones to Alkanes: Wolff–Kishner Reduction
4.4K
Wolff–Kishner reduction involves converting aldehydes and ketones to alkanes using hydrazine and a base. The reaction converts a carbonyl group to a methylene group. The method was independently discovered by N. Kishner in 1911 and L. Wolff in 1912. The reduction is carried out in high-boiling solvents such as ethylene glycol and diethylene glycol because heat is required to deprotonate the N–H proton in one of the reaction steps. ...
4.4K
Phase I Reactions: Reductive Reactions
196
Phase I biotransformation reductive reactions are chemical processes that modify drugs by introducing or revealing polar functional groups via reduction. Enzymes called reductases catalyze these reactions, playing a pivotal role in drug metabolism by transforming lipophilic drugs into more polar, water-soluble metabolites for easy excretion. An essential type of reductive reaction is the carbonyl group reduction, where aldehydes and ketones are reduced to alcohols. An example is the...
196
Reactions of Aldehydes and Ketones: Baeyer–Villiger Oxidation
4.1K
Baeyer–Villiger oxidation converts aldehydes to carboxylic acids and ketones to esters. The reaction uses peroxy acids or peracids and is often catalyzed by acid. The reaction is named after its pioneers, Adolf von Baeyer and Victor Villiger. The reaction is achieved by a wide range of peracids such as m-chloroperoxybenzoic acid (mCPBA), perbenzoic acid (C6H5COOOH), peracetic acid (CH3COOOH), hydrogen peroxide (H2O2), and tert-butyl hydroperoxide (t-BuOOH).
The carbonyl center is...
The carbonyl center is...
4.1K

